- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07291219
Registry of Pavia Chronic Heart Failure Patients-observational Study
December 5, 2025 updated by: Stefano Ghio, Fondazione IRCCS Policlinico San Matteo di Pavia
Registry of Pavia chronic heart failure patients-observational study
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
101
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Stefano Ghio
- Phone Number: 0382503158
- Email: S.Ghio@smatteo.pv.it
Study Locations
-
-
Pavia
-
Pavia, Pavia, Italy, 27100
- Recruiting
- Fondazione IRCCS Policlinico San Matteo di Pavia
-
Contact:
- Stefano Ghio
- Phone Number: 0382503158
- Email: S.Ghio@smatteo.pv.it
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Probability Sample
Study Population
All ambulatory patients with HF in follow up at Fondazione IRCCS Policlinico San Matteo will be prospectively included in this study.
Description
Inclusion Criteria:
- Give written informed consent to participate for the prospective evaluations
- Suffer from CHF
- Be aged 18 years and over
Exclusion Criteria:
- Withdrawn of the consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
accurate and comprehensive data collection for all types of diseases that manifest themselves with heart failure in order to verify the "trajectory" of the disease
Time Frame: From enrollment to the end of treatment at visit 11 (9th years)
|
More specifically, mortality will be assessed one, five, and ten years after the initial diagnosis of heart failure.
|
From enrollment to the end of treatment at visit 11 (9th years)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 22, 2022
Primary Completion (Actual)
December 31, 2024
Study Completion (Estimated)
November 1, 2031
Study Registration Dates
First Submitted
December 5, 2025
First Submitted That Met QC Criteria
December 5, 2025
First Posted (Actual)
December 18, 2025
Study Record Updates
Last Update Posted (Actual)
December 18, 2025
Last Update Submitted That Met QC Criteria
December 5, 2025
Last Verified
August 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHF_22
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.